Literature DB >> 9725501

Determination of lansoprazole in biological fluids and pharmaceutical dosage by HPLC.

A Avgerinos1, T h Karidas, C Potsides, S Axarlis.   

Abstract

A simple and rapid (extractionless) high-performance liquid chromatographic method with UV detection at 230 nm was developed for the determination of lansoprazole in biological fluids and pharmaceutical dosage. Niflumic acid was added as internal standard. The separation was performed at ambient temperature on a C18 Spherisorb column with acetonitrile + 0.1 M sodium acetate (40:60, v/v, pH 7) as mobile phase. The retention time was 5.2 min for niflumic acid and 6.7 min for lansoprazole. The detection limit was 20 ng/ml using a 100 microl loop. The method was successfully applied to a pharmacokinetic study of lansoprazole in humans.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9725501     DOI: 10.1007/BF03189359

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  10 in total

1.  High-performance liquid chromatographic determination of lansoprazole and its metabolites in human serum and urine.

Authors:  I Aoki; M Okumura; T Yashiki
Journal:  J Chromatogr       Date:  1991-11-15

Review 2.  Lansoprazole: pharmacokinetics and pharmacodynamics.

Authors:  I K Moules
Journal:  Br J Clin Pract Suppl       Date:  1994 May-Jun

3.  Pharmacokinetics of lansoprazole in patients with renal or liver disease of varying severity.

Authors:  B Delhotal-Landes; B Flouvat; J Duchier; P Molinie; F Dellatolas; M Lemaire
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

4.  Rapid healing of gastric ulcers with lansoprazole.

Authors:  K D Bardhan; J Ahlberg; W S Hislop; C Lindholmer; R G Long; A G Morgan; S Sjostedt; P M Smith; R Stig; K G Wormsley
Journal:  Aliment Pharmacol Ther       Date:  1994-04       Impact factor: 8.171

Review 5.  Effect of lansoprazole on Helicobacter pylori.

Authors:  H Lamouliatte
Journal:  Clin Ther       Date:  1993       Impact factor: 3.393

6.  Lansoprazole and Helicobacter pylori infection.

Authors:  F Pallone; F Luzza; G Delle Fave; B Annibale; A Marcheggiano; L Biancone; A Torsoli; L Capurso
Journal:  Clin Ther       Date:  1993       Impact factor: 3.393

7.  Determination of lansoprazole and its metabolites in plasma by high-performance liquid chromatography using a loop column.

Authors:  B D Landes; G Miscoria; B Flouvat
Journal:  J Chromatogr       Date:  1992-05-20

8.  Double-blind comparison of lansoprazole, ranitidine, and placebo in the treatment of acute duodenal ulcer. Lansoprazole Study Group.

Authors:  F Lanza; J Goff; C Scowcroft; D Jennings; P Greski-Rose
Journal:  Am J Gastroenterol       Date:  1994-08       Impact factor: 10.864

Review 9.  Treatment of gastroesophageal (acid) reflux with lansoprazole: an overview.

Authors:  G Dobrilla; F Di Fede
Journal:  Clin Ther       Date:  1993       Impact factor: 3.393

Review 10.  Clinical review of lansoprazole.

Authors:  S P Lockhart
Journal:  Br J Clin Pract Suppl       Date:  1994 May-Jun
  10 in total
  1 in total

1.  Simultaneous spectrophotometric determination of lansoprazole and domperidone in capsule dosage form.

Authors:  A P Sherje; A V Kasture; K N Gujar; P G Yeole
Journal:  Indian J Pharm Sci       Date:  2008-01       Impact factor: 0.975

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.